TP53 and neoplasm: Extracellular free-ISG15 has the potential to enhance the immune system exerting an anti-tumour effect not only by activating the innate and adaptive arms of the immune response but also by upregulating p53 expression, thus promoting apoptosis of tumour cells [79] (Table 2).